IDO1 and non-small cell lung carcinoma: For example, IDO is strongly expressed in non-small cell lung cancer, while Trp and kynurenine levels are decreased and increased, respectively, in the lungs of patients, with corresponding changes in the blood levels of these compounds37,38.